Acasti Pharma (ACST) Misses Q2 EPS by 32c

Acasti Pharma (NASDAQ: ACST) reported Q2 EPS of ($0.43), $0.32 worse than the analyst estimate of ($0.11).

For earnings history and earnings-related data on Acasti Pharma (ACST) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Star Equity Holdings (STRR) Misses Q2 EPS by 8c
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c